FDA Adverse Event Injury Summary report: N

WATCHMAN FLX LEFT ATRIAL APPENDAGE CLOSURE DEVICE WITH DELIVERY SYSTEM

MDR report key: 13805167 · Received March 18, 2022

Report

Report Number
2134265-2022-03068
Event Type
Injury
Date Received
March 18, 2022
Date of Event
March 1, 2022
Report Date
March 29, 2022
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NGV
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CORRECTION: H6: PATIENT CODE HAS BEEN UPDATED FROM CVA TO NO CLINICAL SIGNS, SYMPTOMS, OR CONDITIONS AND THIS EVENT IS NO LONGER A COMPLAINT.

Description of Event or Problem · 0

OPTION STUDY. IT WAS REPORTED THAT A CEREBRAL VASCULAR ACCIDENT OCCURRED. A LEFT ATRIAL APPENDAGE (LAA) CLOSURE PROCEDURE WAS SUCCESSFULLY PERFORMED USING A 27 MM WATCHMAN FLX LAA CLOSURE DEVICE WITH DELIVERY SYSTEM (WDS). POST PROCEDURE, ASPIRIN WAS STARTED AND APIXABAN WAS CONTINUED. ON (B)(6) 2019, THE PATIENT WAS DISCHARGED. ON (B)(6) 2022, 867 DAYS POST INDEX PROCEDURE, THE PATIENT WAS HOSPITALIZED FOR A CEREBRAL VASCULAR ACCIDENT (CVA). THE PATIENT WAS TAKING APIXABAN AT THE TIME OF THE EVENT. NO FURTHER INFORMATION IS CURRENTLY AVAILABLE.

Description of Event or Problem · 0

OPTION STUDY. IT WAS REPORTED THAT A CEREBRAL VASCULAR ACCIDENT OCCURRED. A LEFT ATRIAL APPENDAGE (LAA) CLOSURE PROCEDURE WAS SUCCESSFULLY PERFORMED USING A 27 MM WATCHMAN FLX LAA CLOSURE DEVICE WITH DELIVERY SYSTEM (WDS). POST PROCEDURE, ASPIRIN WAS STARTED AND APIXABAN WAS CONTINUED. ON (B)(6) 2019, THE PATIENT WAS DISCHARGED. ON (B)(6) 2022, 867 DAYS POST INDEX PROCEDURE, THE PATIENT WAS HOSPITALIZED FOR A CEREBRAL VASCULAR ACCIDENT (CVA). THE PATIENT WAS TAKING APIXABAN AT THE TIME OF THE EVENT. NO FURTHER INFORMATION IS CURRENTLY AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
15473 WATCHMAN FLX LEFT ATRIAL APPENDAGE CLOSURE DEVICE WITH DELIVERY SYSTEM SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL NGV BOSTON SCIENTIFIC CORPORATION 10393 0022800010

Patients

Seq Age Sex Outcome Treatment
1 65 YR Male Other